メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Taj Pharmaceuticals
Balkan Pharmaceuticals
Bayer
AstraZeneca
Novo Nordisk
BrainAlert
Douglas Laboratories
Onnit Labs
Eli Lilly And Company
1 Performance Enhancing Drugs Market Overview
1.1 Performance Enhancing Drugs Product Overview
1.2 Performance Enhancing Drugs Market Segment by Type
1.2.1 Ergogenic Aids
1.2.2 Nootropic
1.3 Global Performance Enhancing Drugs Market Size by Type
1.3.1 Global Performance Enhancing Drugs Sales and Growth by Type
1.3.2 Global Performance Enhancing Drugs Sales and Market Share by Type (2015-2020)
1.3.3 Global Performance Enhancing Drugs Revenue and Market Share by Type (2015-2020)
1.3.4 Global Performance Enhancing Drugs Price by Type (2015-2020)
2 Global Performance Enhancing Drugs Market Competition by Company
2.1 Global Performance Enhancing Drugs Sales and Market Share by Company (2015-2020)
2.2 Global Performance Enhancing Drugs Revenue and Share by Company (2015-2020)
2.3 Global Performance Enhancing Drugs Price by Company (2015-2020)
2.4 Global Top Players Performance Enhancing Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Performance Enhancing Drugs Market Competitive Situation and Trends
2.5.1 Performance Enhancing Drugs Market Concentration Rate
2.5.2 Global Performance Enhancing Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Performance Enhancing Drugs Company Profiles and Sales Data
3.1 Taj Pharmaceuticals
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Performance Enhancing Drugs Product Category, Application and Specification
3.1.3 Taj Pharmaceuticals Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.1.4 Main Business Overview
3.2 Balkan Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Performance Enhancing Drugs Product Category, Application and Specification
3.2.3 Balkan Pharmaceuticals Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.2.4 Main Business Overview
3.3 Bayer
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Performance Enhancing Drugs Product Category, Application and Specification
3.3.3 Bayer Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.3.4 Main Business Overview
3.4 AstraZeneca
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Performance Enhancing Drugs Product Category, Application and Specification
3.4.3 AstraZeneca Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.4.4 Main Business Overview
3.5 Novo Nordisk
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Performance Enhancing Drugs Product Category, Application and Specification
3.5.3 Novo Nordisk Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.5.4 Main Business Overview
3.6 BrainAlert
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Performance Enhancing Drugs Product Category, Application and Specification
3.6.3 BrainAlert Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.6.4 Main Business Overview
3.7 Douglas Laboratories
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Performance Enhancing Drugs Product Category, Application and Specification
3.7.3 Douglas Laboratories Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.7.4 Main Business Overview
3.8 Onnit Labs
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Performance Enhancing Drugs Product Category, Application and Specification
3.8.3 Onnit Labs Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.8.4 Main Business Overview
3.9 Eli Lilly And Company
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Performance Enhancing Drugs Product Category, Application and Specification
3.9.3 Eli Lilly And Company Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin(2015-2020)
3.9.4 Main Business Overview
4 Performance Enhancing Drugs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Performance Enhancing Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Performance Enhancing Drugs Sales and Revenue by Regions
4.2.1 Global Performance Enhancing Drugs Sales and Market Share by Regions (2015-2020)
4.2.2 Global Performance Enhancing Drugs Revenue and Market Share by Regions (2015-2020)
4.2.3 Global Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 North America Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Performance Enhancing Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Performance Enhancing Drugs Application/End Users
5.1 Performance Enhancing Drugs Segment by Application
5.1.1 Athletes
5.1.2 Body Builders
5.1.3 Students
5.1.4 Militaries
5.2 Global Performance Enhancing Drugs Product Segment by Application
5.2.1 Global Performance Enhancing Drugs Sales by Application
5.2.2 Global Performance Enhancing Drugs Sales and Market Share by Application (2015-2020)
6 Global Performance Enhancing Drugs Market Forecast
6.1 Global Performance Enhancing Drugs Sales, Revenue Forecast (2021-2028)
6.1.1 Global Performance Enhancing Drugs Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Performance Enhancing Drugs Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Performance Enhancing Drugs Forecast by Regions
6.2.1 North America Performance Enhancing Drugs Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Performance Enhancing Drugs Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Performance Enhancing Drugs Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Performance Enhancing Drugs Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Performance Enhancing Drugs Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Performance Enhancing Drugs Forecast by Type
6.3.1 Global Performance Enhancing Drugs Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Ergogenic Aids Gowth Forecast
6.3.3 Nootropic Gowth Forecast
6.4 Performance Enhancing Drugs Forecast by Application
6.4.1 Global Performance Enhancing Drugs Sales Forecast by Application (2021-2028)
6.4.2 Global Performance Enhancing Drugs Forecast in Athletes
6.4.3 Global Performance Enhancing Drugs Forecast in Body Builders
7 Performance Enhancing Drugs Upstream Raw Materials
7.1 Performance Enhancing Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Performance Enhancing Drugs Industrial Chain Analysis
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer